An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions

Histology and Histopathology

Volumn 20, Issue 1, 2005, Pages 59-66

  Xuan, Y H ^a,f   Choi, Y L ^b   Shin, Y K ^c,d   Kook, M C ^c   Chae, S W ^g   Park, S M ^a   Chae, H B ^a   Kim, Seok Hyung ^a,e  

^a Chungbuk National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d DiNonA Inc   (South Korea)

^e Chungbuk National University   (South Korea)

^f YANBIAN UNIVERSITY   (China)

^g Sungkyunkwan University   (South Korea)

Author keywords

Cell cycle; Gallbladder; Immunohistochemistry; MSH2; p53

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CELL CYCLE PROTEIN; CYCLIN D1; HUMAN MISMATCH REPAIR PROTEIN 2; KI 67 ANTIGEN; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADENOMA; ADULT; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; FEMALE; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METAPLASIA; PRECANCER; PROTEIN EXPRESSION;

AGED; CARCINOMA; CELL CYCLE PROTEINS; CYCLIN D1; DNA-BINDING PROTEINS; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MUTS HOMOLOG 2 PROTEIN; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 11144291089     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Arber N., Hibshoosh H., Moss S.F., Sutter T., Zhang Y., Begg M., Wang S., Weinstein I.B. and Holt PR. (1996). Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110, 669-674.
2. Bartkova J., Zemanova M. and Bartek J. (1996). Abundance and subcellular localisation of cyclin D3 in human tumors. Int. J. Cancer. 65, 323-327.
3. Claudio P.P., Zamparelli A., Garcia F.U., Claudio L., Ammirati G., Farina A., Bovicelli A., Russo G., Giordano G.G., McGinnis D.E., Giordano A. and Cardi G. (2002). Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma. Clin. Cancer. Res. 8, 1808-1815.
4. De Jong A.E., Morreau H., Van Puijenbroek M., Eilers P.H., Wijnen J., Nagengast F.M., Griffioen G., Cats A., Menko F.H., Kleibeuker J.H. and Vasen H.F. (2004). The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 126, 42-48.
5. De Paola F., Vecci A.M., Granato A.M., Liverani M., Monti F., Innoceta A.M., Gianni L., Saragoni L., Ricci M., Falcini F., Amadori D. and Volpi A. (2002). p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions. J. Pathol. 196, 26-31.
6. Fero M.L., Randel E., Gurley K.E., Roberts J.M. and Kemp C.J. (1998). The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396, 177-180.
7. Filipits M., Puhalla H. and Wrba F. (2003). Low p27kip1 expression is an independent prognostic factor in gallbladder carcinoma. Anticancer Res. 23, 675-680.
8. Gillett C., Fantl V., Smith R., Fisher C., Bartek J., Dickson C., Barnes D. and Peters G. (1994). Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54, 1812-1817.
9. Greenblatt M.S., Bennett W.P., Hollstein M. and Harris C.C. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
10. Greene F.L., Page D.L., Fleming I.D., Fritz A.G.., Balch C.M., Haller D.G. and Morrow M. (2002). American joint committee on cancer staging manual. 6th ed. Springer. New York. pp 139-144.
11. Harbour J.W. and Dean D.C. (2000). Rb function in cell-cycle regulation and apoptosis. Nat. Cell. Biol. 2, 65-67.
12. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W. and Weinberg R.A. (1999). Nature 400, 464-468.
13. Hirabayashi H., Ohta M., Tanaka H., Sakaguchi M., Fujii Y., Miyoshi S. and Matsuda H. (2002). Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53. J. Surg. Oncol. 81, 177-184.
14. Hommura F., Dosaka-Akita H., Mishina T., Nishi M., Kojima T., Hiroumi H., Ogura S., Shimizu M., Katoh H., Kawakami Y. (2000). Prognostic significance of p27KIP1 protein and Ki-67 growth fraction in non-small cell lung cancers. Clin. Cancer. Res. 6, 4073-4081.
15. Hui A.M., Li X., Shi Y.Z., Takayama T., Torzilli G. and Makuuchi M. (2000a). Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin. Cancer. Res. 6, 4272-4277.
16. Hui A.M., Li X., Shi Y.Z., Torzilli G., Takayama T. and Makuuchi M. (2000b). p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis. Hepatology 31, 1068-1072.
17. Itoi T., Shinohara Y., Takeda K., Nakamura K., Takei K., Sanada J., Horibe T., Saito T., Kasuya K. and Ebihara Y. (2000). Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis. J. Gastroenterol. 35, 142-149.
18. Jiang W., Zhang Y.J., Kahn S.M., Hollstein M.C., Santella R.M., Lu S.H., Harris C.C., Montesano R. and Weinstein I.B. (1993). Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA 90, 9026-9030.
19. Kang Y.K., Kim W.H. and Jang J.J. (2002). Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholagiocarcinoma. Hum. Pathol. 33, 877-883.
20. Kawauchi S., Goto Y., Liu X.P., Furuya T., Oga A., Oda Y., Tsuneyochi M., Ihara K. and Sasaki K. (2001). Low expression of P27(kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma. Cancer 91, 1005-1012.
21. Kim S.H., Jung K.C., Shin Y.K., Lee K.M., Park Y.S., Choi Y.L., Oh K.I., Kim M.K., Chung D.H., Song H.G. and Park S.H. (2002). The enhanced reactivity of endogenous biotin-like molecules by antigen retrieval procedures and signal amplification with tyramine. Histochem. J. 34, 97-103.
22. Kim S.H., Kook M.C., Shin Y.K., Park S.H. and Song H.G. (2004). Evaluation of antigen retrieval systems. J. Mol. Histol. 35, 409-416.
23. Kim S.H., Shin Y.K., Lee K.M., Lee J.S., Yuri J.H. and Lee S.M. (2003). An improved protocol of biotinylated tyramine-based immunohistochemistry minimizing nonspecific background staining. J. Histochem. Cytochem. 51, 129-132.
24. Kohya N., Miyazaki K., Matsukaura S., Yakushiji H., Kitajima Y., Kitahara K., Fukuhara M., Nakabeppu Y. and Sekiguchi M. (2002). Deficient expression of O6-methylguanine-DNA methyltransferase combined with mismatch repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary carcinoma. Ann. Surg. Oncol. 9, 371-379.
25. Lee H.S., Lee H.K., Kim H.S., Yang H.K. and Kim W.H. (2003). Tumour suppressor gene expression correlates with gastric cancer prognosis. J. Pathol. 200, 39-46.
26. Manfredi S., Benhamiche A.M., Isambert N., Prost P., Jouve J.L. and Faivre J. (2000). Trends in incidence and management of gallbladder carcinoma. A population-based study in France. Cancer 89, 757-762.
27. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M., Amenomori M., Shibagaki I., Nakao K. and Ikenaga M. (1994). Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54, 3107-3110.
28. Nita M.E., Nagata H., Tominaga O., Tsuno N., Hatano K., Kitayama J., Tsuruo T., Domene C.E. and Muto T. (1999). p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb. Ann. Surg. Oncol. 6, 481-488.
29. Nitti D., Belluco C., Mammano E., Marchet A., Ambrosi A., Mencarelli R., Segato P. and Lise M. (2002). Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J. Surg. Oncol. 81, 167-175.
30. Noguchi T., Kikuchi R., Ono K., Takeno, S., Moriyama H. and Uchida Y. (2003). Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma. Oncol. Rep. 10, 827-831.
31. Quan Z.W., Wu K., Wang J., Shi W., Zhang Z. and Merrell R.C. (2001). Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer. J. Am. Coll. Surg. 193, 380-383.
32. Sherr C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
33. Sinicrope F.A., Ruan S.B., Cleary K.B., Stephens L.C., Lee J.J. and Levin B. (1995). bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55, 237-241.
34. Tan P., Cady B., Wanner M., Worland P., Cukor B., Magi-Galluzzi C., Lavin P., Draetta G., Pagano M. and Loda M. (1997). The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res. 57, 1259-1263.